
The intersection between healthcare, technology, strategy and impact – Interview with Ochre Bio’s CEO and co-founder Jack O’Meara
Published on July 24, 2023
Today, we had the pleasure to interview Jack O’Meara, CEO and co-founder of Ochre Bio, a pioneering biotechnology company based in Oxford. Since its foundation in 2019, they have been able to secure over €35 million to develop RNA therapies for chronic liver diseases using a combination of genomic deep phenotyping, precision RNA medicine, and…
The post The intersection between healthcare, technology, strategy and impact – Interview with Ochre Bio’s CEO and co-founder Jack O’Meara appeared first on EU-Startups.
